the aid library

LIST OPTIONS

Filter

12008

Download (286)

View PDF (710)

Definitions and reporting framework for tuberculosis – 2013 revision

World Health Organization (2014) C_WHO

(updated December 2014).

Download (147)

View PDF (280)

RWANDA - MATERNAL DEATH SURVEILLANCE AND RESPONSE (MDSR)

World Health Organization (WHO), United Nations Populations Fund (UNFPA) (2015) C_WHO

Country Profile for MDSR Implementation

Download (98)

View PDF (157)

Follow-up and tracing of tuberculosis patients who fail to attend their scheduled appointments in Cotonou, Benin: a retrospective cohort study

Serge Ade1, Arnaud Trébucq, Anthony D. Harries, Gabriel Ade, Gildas Agodokpessi, Prudence Wachinou, Dissou Affolabi, Sévérin Anagonou BMC Health Services Research (2016) C2

Ade et al. BMC Health Services Research (2016) 16:5 Background: In the “Centre National Hospitalier de Pneumo-Phtisiologie” of Cotonou, Benin, little is known about the characteristics of patients who have not attended their scheduled appo... more

Solar and wind energy system Khayelitsha District Hospital (South Africa)

Global Green and Healthy Hospitals (2015) CC

Download (289)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (1086)

View PDF (2210)

Guidelines For Control Of Mosquitoes And Flies In Tsunami Affected Areas

World Health Organization (2004)

COMMUNICATION STRATEGY FOR THE GENDER, CHILDREN, YOUTH AND SPORTS SECTOR WORKING GROUP 2013-2017

Ministry of Health, Malawi (2015)

Download (743)

View PDF (893)

Preventive chemotherapy diseases and transmission control Ghana

World Health Organization (2010) C_WHO

Download (524)

View PDF (1191)

Questions and Answers on vector control for Zika virus

Pan American Health Organization PAHO; World Health Organization, Regional Office for the Americas (2016) C_WHO

Download (456)

View PDF (806)

Adamawa State Integrated Disease Surveillance and Response (IDSR) Nigeria Emergency Response WK 09 2018 (Feb 26 – Mar 04)

World Health Organization, Government of Nigeria (2018) C_WHO

Download (146)

View PDF (224)

Rwanda: Country profile: Violence and injuries - Road safety

World Health Organization (WHO) (2015) C_WHO

Download (139)

View PDF (193)

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO

Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?

Download (114)

View PDF (123)

The Do's and don'ts on Coronavirus Disease (COVID-19)

Ministry of Health (The Republic of Uganda) Ministry of Health (The Republic of Uganda) (2020) C2

Accessed: 08.04.2020

Download (502)

View PDF (239)

Module 4: Essential Components of Antenatal Care and Emergency Obstetric Care

Fistula Care; USAID; Engender Health; et al. (2020) C1

Prevention and Recognition of Obstetric Fistula Training Package Accessed on 2 September 2020

World Malaria Report 2021: Regional data and trends

World Health Organization WHO (2021) C_WHO

This document provides an overview of malaria trends in all WHO regions as contained in the World malaria report 2021. As in past years, the report provides an up-to-date assessment of the burden of malaria at global, regional and country levels.... more

External Link

COVID-19 Vaccine Introduction and deployment Costing tool (‎‎‎‎CVIC tool)

World Health Organization WHO (2022) C_WHO

Version 2.3 , 21 April 2022. The CVIC tool supports credible COVID-19 vaccination costing to facilitate a dialogue with stakeholders, while maintaining sensitivity to protect essential health services. The CVIC tool provides a structured ... comprehensive estimation of incremental operational and selected capital costs of introducing and deploying COVID-19 vaccines, in alignment with the National Deployment and Vaccination Plan (NDVP). This is essential for resource mobilization, budgeting, and delivery strategy refinement and optimization. The tool has been pre-populated with data from global databases and provides a total cost estimate over an immunization programme over the period of 2021-2023, after which COVID-19 vaccination is expected to be integrated into national immunization plans. Countries can customize the priority target populations based on WHO SAGE guidance and select multiple delivery strategies and vaccine products. The tool is available in all six UN working languages (Arabic, Chinese, English, French, Russian and Spanish) and Portuguese. An e-learning course on CVIC is available at OpenWHO. In this updated version 2.3 of the tool, some minor bugs have been fixed and new features have been added more

Download (266)

View PDF (360)

Standard precautions for the prevention and control of infections: aide-memoire
recommended

World Health Organization WHO (2022) C_WHO

Policy statement and recommended actions to lower national salt intakes and lower death rates from high blood pressure and strokes in the Eastern Mediterranean Region

World Health Organization (WHO) World Health Organization (WHO) (2014) C_WHO

The document outlines strategies for reducing salt intake to combat high blood pressure, strokes, and heart disease in the Eastern Mediterranean Region. It highlights the need for progressive reductions in salt consumption, particularly in staple fo... more

Policy statement and recommended actions for reducing fat intake and lowering heart attack rates in the Eastern Mediterranean Region

World Health Organization (WHO) World Health Organization (WHO) (2014) C_WHO

The materials focus on promoting healthy eating habits and reducing risk factors for non-communicable diseases such as obesity, diabetes, and heart... more

Download (1061)

View PDF (1550)

Implementation Research in Health – A Practical Guide

David H. Peters, Nhan T. Tran, Taghreed Adam Alliance for Health Policy and Systems Research (AHPSR) and World Health Organization (2013)

This guide is an attempt to redress the deficit in understanding of implementation research and to encourage programme personnel and implementers to take a greater interest in the subject, recognizi... more

Standard precautions for the prevention and control of infections: aide-memoire recommended

Standard precautions for the prevention and control of infections: aide-memoire
recommended